Original Source(s)
Related Content
GLP-1 Drugs Tied to Lower Addiction Risk
In a target-trial emulation of more than 600,000 veterans, GLP-1 RA initiators saw fewer new substance use disorders—and patients with existing SUDs had fewer overdoses, hospitalizations, and deaths.
May 27, 2026
-
5 min
FDA Monthly Preview: Key June Decisions to Watch
Several FDA decisions across multiple specialties are expected this month.
May 29, 2026
-
3 min
Sleep Program Shifted Teen Circadian Timing
Two-week chronotherapy trial evaluates circadian phase, sleep duration, and alignment outcomes.
May 13, 2026
-
6 min
